Global Liver Failure Therapeutics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Liver Failure Therapeutics Market Size 2017-2028

2.1.2 Liver Failure Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Liver Failure Therapeutics Segment by Type

2.2.1 Ornithine Phenylacetate

2.2.2 MTL-CEBPA

2.2.3 F-573

2.2.4 BL-1220

2.2.5 PP-100

2.2.6 Others

2.3 Liver Failure Therapeutics Market Size by Type

2.3.1 Liver Failure Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Liver Failure Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Liver Failure Therapeutics Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 Others

2.5 Liver Failure Therapeutics Market Size by Application

2.5.1 Liver Failure Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Liver Failure Therapeutics Market Size Market Share by Application (2017-2022)

3 Liver Failure Therapeutics Market Size by Player

3.1 Liver Failure Therapeutics Market Size Market Share by Players

3.1.1 Global Liver Failure Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Liver Failure Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Liver Failure Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Liver Failure Therapeutics by Regions

4.1 Liver Failure Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Liver Failure Therapeutics Market Size Growth (2017-2022)

4.3 APAC Liver Failure Therapeutics Market Size Growth (2017-2022)

4.4 Europe Liver Failure Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Liver Failure Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Liver Failure Therapeutics Market Size by Country (2017-2022)

5.2 Americas Liver Failure Therapeutics Market Size by Type (2017-2022)

5.3 Americas Liver Failure Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Liver Failure Therapeutics Market Size by Region (2017-2022)

6.2 APAC Liver Failure Therapeutics Market Size by Type (2017-2022)

6.3 APAC Liver Failure Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Liver Failure Therapeutics by Country (2017-2022)

7.2 Europe Liver Failure Therapeutics Market Size by Type (2017-2022)

7.3 Europe Liver Failure Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Liver Failure Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Liver Failure Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Liver Failure Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Liver Failure Therapeutics Market Forecast

10.1 Global Liver Failure Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Liver Failure Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Liver Failure Therapeutics Forecast

10.1.3 APAC Liver Failure Therapeutics Forecast

10.1.4 Europe Liver Failure Therapeutics Forecast

10.1.5 Middle East & Africa Liver Failure Therapeutics Forecast

10.2 Americas Liver Failure Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Liver Failure Therapeutics Market Forecast

10.2.2 Canada Liver Failure Therapeutics Market Forecast

10.2.3 Mexico Liver Failure Therapeutics Market Forecast

10.2.4 Brazil Liver Failure Therapeutics Market Forecast

10.3 APAC Liver Failure Therapeutics Forecast by Region (2023-2028)

10.3.1 China Liver Failure Therapeutics Market Forecast

10.3.2 Japan Liver Failure Therapeutics Market Forecast

10.3.3 Korea Liver Failure Therapeutics Market Forecast

10.3.4 Southeast Asia Liver Failure Therapeutics Market Forecast

10.3.5 India Liver Failure Therapeutics Market Forecast

10.3.6 Australia Liver Failure Therapeutics Market Forecast

10.4 Europe Liver Failure Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Liver Failure Therapeutics Market Forecast

10.4.2 France Liver Failure Therapeutics Market Forecast

10.4.3 UK Liver Failure Therapeutics Market Forecast

10.4.4 Italy Liver Failure Therapeutics Market Forecast

10.4.5 Russia Liver Failure Therapeutics Market Forecast

10.5 Middle East & Africa Liver Failure Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Liver Failure Therapeutics Market Forecast

10.5.2 South Africa Liver Failure Therapeutics Market Forecast

10.5.3 Israel Liver Failure Therapeutics Market Forecast

10.5.4 Turkey Liver Failure Therapeutics Market Forecast

10.5.5 GCC Countries Liver Failure Therapeutics Market Forecast

10.6 Global Liver Failure Therapeutics Forecast by Type (2023-2028)

10.7 Global Liver Failure Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Alfact Innovation

11.1.1 Alfact Innovation Company Information

11.1.2 Alfact Innovation Liver Failure Therapeutics Product Offered

11.1.3 Alfact Innovation Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Alfact Innovation Main Business Overview

11.1.5 Alfact Innovation Latest Developments

11.2 BioLineRx Ltd

11.2.1 BioLineRx Ltd Company Information

11.2.2 BioLineRx Ltd Liver Failure Therapeutics Product Offered

11.2.3 BioLineRx Ltd Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 BioLineRx Ltd Main Business Overview

11.2.5 BioLineRx Ltd Latest Developments

11.3 Cell2B Advanced Therapeutics SA

11.3.1 Cell2B Advanced Therapeutics SA Company Information

11.3.2 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product Offered

11.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Cell2B Advanced Therapeutics SA Main Business Overview

11.3.5 Cell2B Advanced Therapeutics SA Latest Developments

11.4 Conatus Pharmaceuticals Inc

11.4.1 Conatus Pharmaceuticals Inc Company Information

11.4.2 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product Offered

11.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Conatus Pharmaceuticals Inc Main Business Overview

11.4.5 Conatus Pharmaceuticals Inc Latest Developments

11.5 Immune Pharmaceuticals Inc

11.5.1 Immune Pharmaceuticals Inc Company Information

11.5.2 Immune Pharmaceuticals Inc Liver Failure Therapeutics Product Offered

11.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Immune Pharmaceuticals Inc Main Business Overview

11.5.5 Immune Pharmaceuticals Inc Latest Developments

11.6 Mina Therapeutics Ltd

11.6.1 Mina Therapeutics Ltd Company Information

11.6.2 Mina Therapeutics Ltd Liver Failure Therapeutics Product Offered

11.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Mina Therapeutics Ltd Main Business Overview

11.6.5 Mina Therapeutics Ltd Latest Developments

11.7 Mylan NV

11.7.1 Mylan NV Company Information

11.7.2 Mylan NV Liver Failure Therapeutics Product Offered

11.7.3 Mylan NV Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Mylan NV Main Business Overview

11.7.5 Mylan NV Latest Developments

11.8 Ocera Therapeutics Inc

11.8.1 Ocera Therapeutics Inc Company Information

11.8.2 Ocera Therapeutics Inc Liver Failure Therapeutics Product Offered

11.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Ocera Therapeutics Inc Main Business Overview

11.8.5 Ocera Therapeutics Inc Latest Developments

11.9 PledPharma AB

11.9.1 PledPharma AB Company Information

11.9.2 PledPharma AB Liver Failure Therapeutics Product Offered

11.9.3 PledPharma AB Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 PledPharma AB Main Business Overview

11.9.5 PledPharma AB Latest Developments

11.10 Promethera Biosciences SA

11.10.1 Promethera Biosciences SA Company Information

11.10.2 Promethera Biosciences SA Liver Failure Therapeutics Product Offered

11.10.3 Promethera Biosciences SA Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Promethera Biosciences SA Main Business Overview

11.10.5 Promethera Biosciences SA Latest Developments

11.11 Silence Therapeutics Plc

11.11.1 Silence Therapeutics Plc Company Information

11.11.2 Silence Therapeutics Plc Liver Failure Therapeutics Product Offered

11.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Silence Therapeutics Plc Main Business Overview

11.11.5 Silence Therapeutics Plc Latest Developments

11.12 Unicyte AG

11.12.1 Unicyte AG Company Information

11.12.2 Unicyte AG Liver Failure Therapeutics Product Offered

11.12.3 Unicyte AG Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Unicyte AG Main Business Overview

11.12.5 Unicyte AG Latest Developments

11.13 Ventria Bioscience

11.13.1 Ventria Bioscience Company Information

11.13.2 Ventria Bioscience Liver Failure Therapeutics Product Offered

11.13.3 Ventria Bioscience Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Ventria Bioscience Main Business Overview

11.13.5 Ventria Bioscience Latest Developments

11.14 Vital Therapies Inc

11.14.1 Vital Therapies Inc Company Information

11.14.2 Vital Therapies Inc Liver Failure Therapeutics Product Offered

11.14.3 Vital Therapies Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Vital Therapies Inc Main Business Overview

11.14.5 Vital Therapies Inc Latest Developments

12 Research Findings and Conclusion

Table 1. Liver Failure Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Ornithine Phenylacetate

Table 3. Major Players of MTL-CEBPA

Table 4. Major Players of F-573

Table 5. Major Players of BL-1220

Table 6. Major Players of PP-100

Table 7. Major Players of Others

Table 8. Liver Failure Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Liver Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 10. Global Liver Failure Therapeutics Market Size Market Share by Type (2017-2022)

Table 11. Liver Failure Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 12. Global Liver Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 13. Global Liver Failure Therapeutics Market Size Market Share by Application (2017-2022)

Table 14. Global Liver Failure Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 15. Global Liver Failure Therapeutics Revenue Market Share by Player (2020-2022)

Table 16. Liver Failure Therapeutics Key Players Head office and Products Offered

Table 17. Liver Failure Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 18. New Products and Potential Entrants

Table 19. Mergers & Acquisitions, Expansion

Table 20. Global Liver Failure Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 21. Global Liver Failure Therapeutics Market Size Market Share by Regions (2017-2022)

Table 22. Americas Liver Failure Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 23. Americas Liver Failure Therapeutics Market Size Market Share by Country (2017-2022)

Table 24. Americas Liver Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 25. Americas Liver Failure Therapeutics Market Size Market Share by Type (2017-2022)

Table 26. Americas Liver Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 27. Americas Liver Failure Therapeutics Market Size Market Share by Application (2017-2022)

Table 28. APAC Liver Failure Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 29. APAC Liver Failure Therapeutics Market Size Market Share by Region (2017-2022)

Table 30. APAC Liver Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 31. APAC Liver Failure Therapeutics Market Size Market Share by Type (2017-2022)

Table 32. APAC Liver Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 33. APAC Liver Failure Therapeutics Market Size Market Share by Application (2017-2022)

Table 34. Europe Liver Failure Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 35. Europe Liver Failure Therapeutics Market Size Market Share by Country (2017-2022)

Table 36. Europe Liver Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 37. Europe Liver Failure Therapeutics Market Size Market Share by Type (2017-2022)

Table 38. Europe Liver Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 39. Europe Liver Failure Therapeutics Market Size Market Share by Application (2017-2022)

Table 40. Middle East & Africa Liver Failure Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Liver Failure Therapeutics Market Size Market Share by Region (2017-2022)

Table 42. Middle East & Africa Liver Failure Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Liver Failure Therapeutics Market Size Market Share by Type (2017-2022)

Table 44. Middle East & Africa Liver Failure Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Liver Failure Therapeutics Market Size Market Share by Application (2017-2022)

Table 46. Key Market Drivers & Growth Opportunities of Liver Failure Therapeutics

Table 47. Key Market Challenges & Risks of Liver Failure Therapeutics

Table 48. Key Industry Trends of Liver Failure Therapeutics

Table 49. Global Liver Failure Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 50. Global Liver Failure Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 51. Global Liver Failure Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 52. Global Liver Failure Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 53. Global Liver Failure Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 54. Global Liver Failure Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 55. Alfact Innovation Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 56. Alfact Innovation Liver Failure Therapeutics Product Offered

Table 57. Alfact Innovation Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 58. Alfact Innovation Main Business

Table 59. Alfact Innovation Latest Developments

Table 60. BioLineRx Ltd Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 61. BioLineRx Ltd Liver Failure Therapeutics Product Offered

Table 62. BioLineRx Ltd Main Business

Table 63. BioLineRx Ltd Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 64. BioLineRx Ltd Latest Developments

Table 65. Cell2B Advanced Therapeutics SA Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 66. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product Offered

Table 67. Cell2B Advanced Therapeutics SA Main Business

Table 68. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 69. Cell2B Advanced Therapeutics SA Latest Developments

Table 70. Conatus Pharmaceuticals Inc Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 71. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product Offered

Table 72. Conatus Pharmaceuticals Inc Main Business

Table 73. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 74. Conatus Pharmaceuticals Inc Latest Developments

Table 75. Immune Pharmaceuticals Inc Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 76. Immune Pharmaceuticals Inc Liver Failure Therapeutics Product Offered

Table 77. Immune Pharmaceuticals Inc Main Business

Table 78. Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 79. Immune Pharmaceuticals Inc Latest Developments

Table 80. Mina Therapeutics Ltd Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 81. Mina Therapeutics Ltd Liver Failure Therapeutics Product Offered

Table 82. Mina Therapeutics Ltd Main Business

Table 83. Mina Therapeutics Ltd Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 84. Mina Therapeutics Ltd Latest Developments

Table 85. Mylan NV Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 86. Mylan NV Liver Failure Therapeutics Product Offered

Table 87. Mylan NV Main Business

Table 88. Mylan NV Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 89. Mylan NV Latest Developments

Table 90. Ocera Therapeutics Inc Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 91. Ocera Therapeutics Inc Liver Failure Therapeutics Product Offered

Table 92. Ocera Therapeutics Inc Main Business

Table 93. Ocera Therapeutics Inc Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 94. Ocera Therapeutics Inc Latest Developments

Table 95. PledPharma AB Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 96. PledPharma AB Liver Failure Therapeutics Product Offered

Table 97. PledPharma AB Main Business

Table 98. PledPharma AB Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 99. PledPharma AB Latest Developments

Table 100. Promethera Biosciences SA Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 101. Promethera Biosciences SA Liver Failure Therapeutics Product Offered

Table 102. Promethera Biosciences SA Main Business

Table 103. Promethera Biosciences SA Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Promethera Biosciences SA Latest Developments

Table 105. Silence Therapeutics Plc Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 106. Silence Therapeutics Plc Liver Failure Therapeutics Product Offered

Table 107. Silence Therapeutics Plc Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 108. Silence Therapeutics Plc Main Business

Table 109. Silence Therapeutics Plc Latest Developments

Table 110. Unicyte AG Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 111. Unicyte AG Liver Failure Therapeutics Product Offered

Table 112. Unicyte AG Main Business

Table 113. Unicyte AG Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 114. Unicyte AG Latest Developments

Table 115. Ventria Bioscience Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 116. Ventria Bioscience Liver Failure Therapeutics Product Offered

Table 117. Ventria Bioscience Main Business

Table 118. Ventria Bioscience Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 119. Ventria Bioscience Latest Developments

Table 120. Vital Therapies Inc Details, Company Type, Liver Failure Therapeutics Area Served and Its Competitors

Table 121. Vital Therapies Inc Liver Failure Therapeutics Product Offered

Table 122. Vital Therapies Inc Main Business

Table 123. Vital Therapies Inc Liver Failure Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 124. Vital Therapies Inc Latest Developments

List of Figures

Figure 1. Liver Failure Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Liver Failure Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Liver Failure Therapeutics Market Size Market Share by Type in 2021

Figure 7. Liver Failure Therapeutics in Clinic

Figure 8. Global Liver Failure Therapeutics Market: Clinic (2017-2022) & ($ Millions)

Figure 9. Liver Failure Therapeutics in Hospital

Figure 10. Global Liver Failure Therapeutics Market: Hospital (2017-2022) & ($ Millions)

Figure 11. Liver Failure Therapeutics in Others

Figure 12. Global Liver Failure Therapeutics Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Liver Failure Therapeutics Market Size Market Share by Application in 2021

Figure 14. Global Liver Failure Therapeutics Revenue Market Share by Player in 2021

Figure 15. Global Liver Failure Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Liver Failure Therapeutics Market Size 2017-2022 ($ Millions)

Figure 17. APAC Liver Failure Therapeutics Market Size 2017-2022 ($ Millions)

Figure 18. Europe Liver Failure Therapeutics Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Liver Failure Therapeutics Market Size 2017-2022 ($ Millions)

Figure 20. Americas Liver Failure Therapeutics Value Market Share by Country in 2021

Figure 21. Americas Liver Failure Therapeutics Consumption Market Share by Type in 2021

Figure 22. Americas Liver Failure Therapeutics Market Size Market Share by Application in 2021

Figure 23. United States Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Liver Failure Therapeutics Market Size Market Share by Region in 2021

Figure 28. APAC Liver Failure Therapeutics Market Size Market Share by Application in 2021

Figure 29. China Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Liver Failure Therapeutics Market Size Market Share by Country in 2021

Figure 36. Europe Liver Failure Therapeutics Market Size Market Share by Type in 2021

Figure 37. Europe Liver Failure Therapeutics Market Size Market Share by Application in 2021

Figure 38. Germany Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Liver Failure Therapeutics Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Liver Failure Therapeutics Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Liver Failure Therapeutics Market Size Market Share by Application in 2021

Figure 46. Egypt Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Liver Failure Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 52. APAC Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 53. Europe Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. United States Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Canada Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. China Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Japan Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. Korea Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. India Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. Australia Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. Germany Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. France Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. UK Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. Italy Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. Russia Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. Spain Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. Israel Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Liver Failure Therapeutics Market Size 2023-2028 ($ Millions)